Publications by authors named "Youming Ding"

Claim this Profile
A
A novel miRNA-based model for predicting the 3-year recurrence risk of hepatocellular carcinoma following liver transplantation.
Bin Yu, Youming Ding

J Gastrointest Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis.
Jie Shen, Zhongkai Wu, Yu Zhou, Dashuai Yang, Xin Wang, Youming Ding

Biochem Biophys Res Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of prognostic models for advanced multiple hepatocellular carcinoma based on Cox regression, deep learning and machine learning algorithms.
Jie Shen, Yu Zhou, Junpeng Pei, Dashuai Yang, Kailiang Zhao, Youming Ding

Front Med (Lausanne)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S100A16 is a potential target for reshaping the tumor microenvironment in the hypoxic context of liver cancer.
Dashuai Yang, Fangrui Zhao, Yu Zhou, Yanbing Zhang, Jie Shen, Youming Ding

Int Immunopharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of machine learning models for patients in the high intrahepatic cholangiocarcinoma incidence age group.
Jie Shen, Dashuai Yang, Yu Zhou, Junpeng Pei, Zhongkai Wu, Youming Ding

BMC Geriatr· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of scRNA-Seq and bulk RNA-Seq data reveals dynamic changes in tumor-associated neutrophils in the tumor microenvironment of hepatocellular carcinoma and leads to the establishment of a neutrophil-related prognostic model.
Dashuai Yang, Yu Zhou, Yanbing Zhang, Yang Su, Jie Shen, Youming Ding

Cancer Immunol Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-associated endothelial cell prognostic risk model and tumor immune environment modulation in liver cancer based on single-cell and bulk RNA sequencing: Experimental verification.
Dashuai Yang, Tianrui Kuang, Yu Zhou, Yang Su, Jie Shen, Youming Ding

Int Immunopharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.
Jie Shen, Yu Zhou, Bin Yu, Kailiang Zhao, Youming Ding

Eur J Surg Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma.
Dashuai Yang, Fangrui Zhao, Yang Su, Yu Zhou, Jie Shen, Youming Ding

J Cancer Res Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy.
Dashuai Yang, Fangrui Zhao, Yang Su, Yu Zhou, Jie Shen, Youming Ding

Front Mol Biosci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features and Prognostic Models in Patients with Intrahepatic Cholangiocarcinoma: a Population-Based Analysis.
Kailiang Zhao, Dashuai Yang, Yu Zhou, Youming Ding

J Gastrointest Surg· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study.
Dashuai Yang, Yang Su, Fangrui Zhao, Yong Hu, Kailiang Zhao, Youming Ding

Expert Rev Gastroenterol Hepatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 in diallyl trisulfide-induced cytotoxicity in hepatocellular carcinoma cells.
Feng Guan, Youming Ding, Yikang He, Lu Li, Xinyu Yang

Korean J Physiol Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma.
Fangrui Zhao, Dashuai Yang, Jiahui He, Xianli Ju, Youming Ding

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Promoting the Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Hepatocellular Carcinoma.
Jie Shen, Dashuai Yang, Youming Ding

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database.
Dashuai Yang, Mingqiang Zhu, Xiangyun Xiong, Yang Su, Fangrui Zhao, Youming Ding

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Practical Nomogram and Risk Stratification System Predicting the Cancer-Specific Survival for Patients With Advanced Hepatocellular Carcinoma.
Dashuai Yang, Yang Su, Fangrui Zhao, Chen Chen, Kailiang Zhao, Youming Ding

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver Fibrosis.
Dashuai Yang, Yang Su, Fangrui Zhao, Chen Chen, Kailiang Zhao, Youming Ding

Front Surg· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis.
Bin Wang, Kailiang Zhao, Wenjuan Hu, Youming Ding, Weixing Wang

Dig Dis Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of ubiquitin-conjugating enzyme E2Z is associated with human hepatocellular carcinoma.
Xiaokang Shi, Bin Wang, Xiaoyan Chen, Yuyang Zheng, Youming Ding

Biochem Biophys Res Commun· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Bin Yu, Youming Ding, Xiaofeng Liao, Changhua Wang, Bin Wang

Dig Dis Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Bin Yu, Youming Ding, Xiaofeng Liao, Changhua Wang, Bin Wang

Pathol Res Pract· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage Migration Inhibitor Promoted the Intrahepatic Bile Duct Injury in Rats with Severe Acute Pancreatitis.
Bin Wang, Kai-Liang Zhao, Wen-Juan Hu, Teng Zuo, You-Ming Ding

Dig Dis Sci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
Bin Yu, Youming Ding, Xiaofeng Liao, Changhua Wang, Bin Wang

Saudi J Gastroenterol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage migration inhibitory factor antagonist (S,R)3‑(4‑hydroxyphenyl)‑4,5‑dihydro‑5‑isoxazole acetic acid methyl ester attenuates inflammation and lung injury in rats with acute pancreatitis in pregnancy.
Yu Zhou, Liang Zhao, Fangchao Mei, Yupu Hong, He Xia, Youming Ding

Mol Med Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis